Point72 Asset Management
GSK icon

Point72 Asset Management’s GSK GSK Stock Holding History

Point72 Asset Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,474,951
Closed -$72.3M – 4070
2025
Q4 		$72.3M Buy
+1,474,951
New +$68.8M 0.08% 278
2024
Q2 		– Sell
-543,100
Closed -$23.3M – 2092
2024
Q1 		$23.3M Buy
543,100
+518,300
+2,090% +$21.4M 0.06% 408
2023
Q4 		$919K Buy
+24,800
New +$890K ﹤0.01% 1419
2023
Q2 		– Sell
-106,100
Closed -$3.78M – 2413
2023
Q1 		$3.78M Sell
106,100
-6,365,673
-98% -$223M 0.01% 840
2022
Q4 		$227M Buy
6,471,773
+1,849,922
+40% +$61.6M 0.77% 13
2022
Q3 		$136M Buy
4,621,851
+2,657,852
+135% +$101M 0.54% 25
2022
Q2 		$107M Buy
1,963,999
+1,472,799
+300% +$81.3M 0.45% 35
2022
Q1 		$26.7M Buy
491,200
+210,720
+75% +$11.4M 0.11% 252
2021
Q4 		$15.5M Buy
+280,480
New +$14.6M 0.06% 397
2021
Q1 		– Sell
-204,000
Closed -$9.38M – 1044
2020
Q4 		$9.38M Buy
+204,000
New +$9.37M 0.05% 451
2019
Q4 		– Sell
-32,400
Closed -$1.73M – 1062
2019
Q3 		$1.73M Sell
32,400
-851,738
-96% -$43.8M 0.01% 616
2019
Q2 		$44.2M Buy
884,138
+692,812
+362% +$34.8M 0.23% 112
2019
Q1 		$9.99M Buy
+191,326
New +$9.56M 0.05% 404
2017
Q4 		– Sell
-483,535
Closed -$24.5M – 969
2017
Q3 		$24.5M Buy
483,535
+403,535
+504% +$20.5M 0.11% 221
2017
Q2 		$4.31M Buy
+80,000
New +$4.26M 0.02% 533
2016
Q1 		– Sell
-69,680
Closed -$3.51M – 772
2015
Q4 		$3.51M Buy
+69,680
New +$3.55M 0.03% 466

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Point72 Asset Management's GSK Position: Q1 2026 in Review

Point72 Asset Management sold out of GSK (GSK) in Q1 2026, closing a stake of 1,474,951 shares — an estimated $72.3M sold.

Point72 Asset Management first reported a position in GSK in Q4 2015 and held it in 16 quarters. The position peaked at $227M in Q4 2022. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Point72 Asset Management reported no remaining GSK position as of Q1 2026 after selling out during the quarter.
  • Point72 Asset Management sold 1,474,951 GSK shares in Q1 2026, an estimated $72.3M.
  • Point72 Asset Management first reported a position in GSK in Q4 2015 and held it in 16 quarters.
  • Point72 Asset Management's GSK position peaked at $227M in Q4 2022.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.